Background Since the release of the first global hepatitis elimination targets in 2016, and
until the COVID-19 pandemic started in early 2020, many countries and territories were …

Summary Background The 69th World Health Assembly approved the Global Health Sector
Strategy to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality …

Background The revolution in hepatitis C virus (HCV) treatment through the development of
direct-acting antivirals (DAAs) has generated international interest in the global elimination …

Chronic HCV infection is a global health problem that affects> 184 million people worldwide.
HCV is associated with several hepatic and extrahepatic disorders, including several …

Background Since the release of the first global hepatitis elimination targets in 2016, and
until the COVID-19 pandemic started in early 2020, many countries and territories were …

A nationwide programme for the treatment of all patients infected with hepatitis C virus
(HCV) was launched in Iceland in January 2016. By providing universal access to direct …

The management of acute HCV infection has not been standardized following the
availability of direct-acting antiviral agents (DAAs) for chronic HCV infection, and substantial …

Abstract Background The World Health Organization (WHO) has developed a global health
strategy to eliminate viral hepatitis. We project the treatment and prevention requirements to …

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections pose serious problems in
terms of public health and clinical intervention in a country with approximately 250 million …

Detailed, country‐specific epidemiological data are needed to characterize the burden of
chronic hepatitis C virus (HCV) infection around the world. With new treatment options …